Buspirone Hydrochloride Tablet
Product Images NDC 80425-0334

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 80425-0334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1 (Busprione HCl 5mg 80425 0334 01)

BUSPIRONE HCL 5 MG TABLET packaging label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes NDC 80425-0334-01, lot number, and expiration date 1/31/2024. It mentions comparison to BUSPAR and includes storage instructions (20-25°C). The label also shows barcodes and other product identifiers.*

FDA Label Image

Label2 (Busprione HCl 5mg 80425 0334 02)

BUSPIRONE HCL 5MG TABLET packaging label showing a 5 mg oral tablet of buspirone hydrochloride. The label includes the product NDC 80425-0334-02 and lot expiration date of 1/31/2024. It is packed by Advanced Rx Pharmacy of Tennessee, LLC, and mentions comparison to BUSPAR with source NDC 59651-0389-05.*

FDA Label Image

Label 3 (Busprione HCl 5mg 80425 0334 03)

Packaging label for BUSPIRONE HCL 5MG TABLET, an oral tablet containing buspirone hydrochloride. The label shows a 5 mg strength, is packed by Advanced Rx Pharmacy of Tennessee, LLC in Nashville, TN, and includes the product NDC 80425-0334. The label references a comparison to BUSPAR and displays lot and expiration information, with an expiration date of 1/31/2024.*

FDA Label Image

Patient Instruction Sheet (Buspirone Fig1)

An instructional diagram showing the appearance and subdivisions of buspirone hydrochloride tablets in 30 mg and 15 mg strengths. The front sides of the tablets are imprinted with "B 3 0" for 30 mg and "B 1 5" for 15 mg. The image also depicts how the tablets can be broken into halves or thirds to achieve various dosages, displaying the respective imprints on the subdivided portions.*

FDA Label Image

Figure (Buspirone Fig2)

An instructional line drawing showing hands holding a blister pack of tablets, with one tablet being pushed out through the blister foil. It demonstrates how to properly remove a tablet from the packaging for oral administration.*

FDA Label Image

Chemical Structure (Buspirone Str)

Chemical structure of buspirone hydrochloride showing its molecular arrangement with various rings and functional groups, including piperazine and pyrimidine moieties, and a hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.